Trials / Completed
CompletedNCT04707144
Performance Evaluation of a 3D PSIR Sequence in MRI at 1.5T
Performance Evaluation of a 3D PSIR Sequence in MRI at 1.5T in the Detection and Characterization of Spinal Cord Injuries in Patients With Multiple Sclerosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 106 (actual)
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Inclusion visit (D0): * verification of inclusion and non-inclusion criteria * information and collection of consent * standard imaging protocol prescribed as part of the usual treatment: sagittal T1 and T2 slices after injection of contrast product (Gadolinium), o 3D STIR sequence. * 3D PSIR sequence at the level of the cervical cord for the duration of the additional sequence is 10 minutes, for a total examination time of 45 minutes (instead of 35 minutes).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MRI 1.5 tesla | * standard imaging protocol prescribed as part of the usual treatment: sagittal T1 and T2 slices after injection of contrast product (Gadolinium), o 3D STIR sequence. * 3D PSIR sequence at the level of the cervical cord for the duration of the additional sequence is 10 minutes, for a total examination time of 45 minutes (instead of 35 minutes) |
Timeline
- Start date
- 2021-05-06
- Primary completion
- 2023-06-06
- Completion
- 2023-06-28
- First posted
- 2021-01-13
- Last updated
- 2023-12-13
Locations
6 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04707144. Inclusion in this directory is not an endorsement.